Ignite Creation Date:
2024-05-06 @ 3:08 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02213133
Status:
TERMINATED
Last Update Posted:
2023-01-26
First Post:
2014-08-07
Brief Title:
Selinexor Treatment of Advanced RelapsedRefractory Squamous Cell Carcinomas
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Karyopharm Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-07
First Submit QC Date:
August 7 2014
Study First Post Date:
2014-08-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-12-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-24
Last Update Post Date:
2023-01-26
Last Update Post Date Type:
ACTUAL